Myopathy and eosinophilic pneumonia coincidentally induced by treatment with daptomycin

Hideharu Hagiya, Kou Hasegawa, Kikuko Asano, Tomohiro Terasaka, Kosuke Kimura, Takahiro Nada, Eri Nakamura, Koichi Waseda, Yoshihisa Hanayama, Fumio Otsuka

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)


A 34-year-old man with 22q11.2 deletion syndrome (DiGeorge syndrome) concurrently suffered from myopathy and eosinophilic pneumonia shortly after receiving daptomycin (DAP) for right-sided infective endocarditis. The simultaneous occurrence of these phenomena in relation to DAP therapy has not been previously well described. An allergic reaction was suspected as a possible etiology of these DAP-related complications. This case highlights the need for close observation in order to detect both musculoskeletal and respiratory disorders from the start of DAP therapy. Physicians should pay more attention to this new drug, which is expected to be frequently used in various clinical settings.

Original languageEnglish
Pages (from-to)525-529
Number of pages5
JournalInternal Medicine
Issue number5
Publication statusPublished - Mar 1 2015


  • Daptomycin
  • Eosinophilic pneumonia (EP)
  • Musculoskeletal injury
  • Rhabdomyolysis

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Myopathy and eosinophilic pneumonia coincidentally induced by treatment with daptomycin'. Together they form a unique fingerprint.

Cite this